Lobbyist information

Amount

John F Heffernan	$0.00
Employed Terminated 01/01/2016

Total salaries paid:      $0.00

Client information

Amount

Biotechnology Innovation Organization (BIO)	$60,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2016 All Legislation and Executive Branch activities in the Commonwealth including, but not limited to, agriculture, health care, taxation, and other issues pertaining to biotechnology

kaléo	$29,133.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2016 08/31/2016 Opioid analgesics, naloxone, overdose prevention policies.

Massachusetts Biotechnology Council

$120,000.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2016 Any and all legislation and regulations pertaining to the healthcare system; Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors/markets in the Commonwealth; any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth's; implementation of Chapter 224 the Acts of 2012, Pharmaceutical Cost Containment Commission, drug innovation, pharmaceuticals, recycling and disposal policies, provider and industry practices related to pharmaceuticals, prescribing, dispensing and monitoring controlled substances and related policies, patient access and prescribing related policies, Massachusetts Life Sciences Center, research and development, taxation policies, drug safety, recycling and disposal policies greenbio policies, any and all legislation, regulation, policy matters pending before the legislature or executive branch including not limited to DPH, DOI, HCQCC, and HPC.

Shire	$66,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/04/2016 Any and all Legislative/Executive matters concerning economic development for Shire.

UCB, Inc.

$31,500.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 04/01/2016 Any issue that impacts a biopharmaceutical company's ability to market or sell its products in all sectors/markets in the Commonwealth; any laws or regulations that impose or levy taxes upon a biopharmaceutical company doing business in the Commonwealth; any laws or regulations which provided incentives or disincentives to biopharmaceutical companies conducting research in the Commonwealth; and, any policy or proposal that seeks to limit or restrict unfettered patient access to innovative medicines and therapies in the Commonwealth's Medicaid or other publicly funded and reimbursed programs

Total salaries received:      $306,633.00

Expenditures

Amount